focus -WSS

focus

author：comprehensive 2025-09-28 00:50:55 - browse：3579

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： The world needs the new pandemic treaty

WSS

Telehealth startups turn to complex chronic diseases

Why we need mandatory labeling of GMO products

Telehealth startups turn to complex chronic diseases

Bird flu outbreak in cows is latest avian flu curveball

First recipient of genetically engineered pig kidney has died

The Bio Revolution is changing business and society

entertainment

focus

Wikipedia

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Study: AI not yet building 'n

DIEP, the 'gold standard' of breast reconstruction, is under threat

U.S. death rates show how politics are affecting public health

Sports medicine is finally prioritizing gender equality

Medical students need to learn the potent medicine of empathy

Activists slam private health insurers over coverage restrictions

Bird flu makes raw milk dangerous to consume, mouse study finds

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Sanofi strikes deal with Novavax, boosting the vaccine maker

focus

Bird flu outbreak in cows is latest avian flu curveball

The world needs the new pandemic treaty

Should insurance cover cosmetic surgery?

Medical students need to learn the potent medicine of empathy

Achieving telehealth equity for people with hearing loss

CDC wastewater surveillance dashboard to track bird flu hotspots

focus

Wikipedia

knowledge

leisure time